% Expired Patents = 100.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 69

Loading Chart...

3 inventors (with patents filed for the assignee):

Perry Calias (4 out of 7 patents)

David Shima (4 out of 4 patents)

Anthony P Adamis (4 out of 4 patents)

4. David Shima (0 patent)

4 patents: Sort by Forward Citations

1. 8685397 - Combination therapy for the treatment of ocular neovascular disorders (2014-04-01),

2. 8206707 - Combination therapy for the treatment of ocular neovascular disorders (2012-06-26),

3. 8187597 - Combination therapy for the treatment of ocular neovascular disorders (2012-05-29),

4. 7759472 - Combination therapy for the treatment of ocular neovascular disorders (2010-07-20),

Ophthotech Corporation is a biopharmaceutical company focused on the development of novel treatment options for patients with back-of-the-eye diseases. The company's pipeline includes potential therapies for age-related macular degeneration and other retinal disorders. Ophthotech is committed to advancing innovative solutions that improve the lives of patients with vision-threatening conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#1,390 in New York, NY

#3,673 in New York

#60,533 in US

New York, NY, United States of America

Ophthotech Corporation

Forward Citations = 69

3 inventors:

Perry Calias (4 out of 7 patents)

David Shima (4 out of 4 patents)

Anthony P Adamis (4 out of 4 patents)

4. David Shima (0 patent)

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]